Algeria vs United Kingdom of Great Britain and Northern Ireland: Immunization, Hib3
Immunization, Hib3 over time
- Algeria
- United Kingdom of Great Britain and Northern Ireland
How they compare
Algeria currently reports 92.0% against 92.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 0.0%.
The two have swapped places 1 time across 17 shared years of data; in 2008 it was Algeria ahead.
Algeria ranks 84th and United Kingdom of Great Britain and Northern Ireland ranks 84th of 191 countries.
Across the 3 decades both report, Algeria averaged higher in 1 and United Kingdom of Great Britain and Northern Ireland in 2.
Head to head by decade
| Decade | Algeria | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.0% | 92.5% | 1.5% | Algeria |
| 2010s | 93.1% | 94.4% | 1.3% | United Kingdom of Great Britain and Northern Ireland |
| 2020s | 85.2% | 92.4% | 7.2% | United Kingdom of Great Britain and Northern Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Algeria or United Kingdom of Great Britain and Northern Ireland?
- Algeria, at 92.0% against 92.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
- What is the difference in immunization, hib3 between Algeria and United Kingdom of Great Britain and Northern Ireland?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and United Kingdom of Great Britain and Northern Ireland?
- 17 years are reported by both, from 2008 to 2024.
- How do Algeria and United Kingdom of Great Britain and Northern Ireland rank globally for immunization, hib3?
- Algeria ranks 84th and United Kingdom of Great Britain and Northern Ireland ranks 84th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.